Estrogen and thrombosis

Controversies and common sense

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    Soon after the introduction of hormonal oral contraceptive agents reports of thrombotic complications appeared. In the past several decades, large epidemiological studies helped defined these risks for both arterial and venous complications. Clinicians can assess a patient's risk of thrombosis by both composition of the agent and patients' personal risk factors. For women with bleeding disorders these prothrombotic changes can help decrease bleeding complications. There is now also abundant data on future management of patients with estrogen related thrombosis.

    Original languageEnglish (US)
    Pages (from-to)77-84
    Number of pages8
    JournalReviews in Endocrine and Metabolic Disorders
    Volume12
    Issue number2
    DOIs
    StatePublished - Jun 2011

    Fingerprint

    Contraceptives, Oral, Hormonal
    Estrogens
    Thrombosis
    Hemorrhage
    Proxy
    Epidemiologic Studies

    Keywords

    • Estrogen
    • Myocardial infraction
    • Stroke
    • Thrombophilia
    • Thrombosis

    ASJC Scopus subject areas

    • Endocrinology
    • Endocrinology, Diabetes and Metabolism

    Cite this

    Estrogen and thrombosis : Controversies and common sense. / Deloughery, Thomas.

    In: Reviews in Endocrine and Metabolic Disorders, Vol. 12, No. 2, 06.2011, p. 77-84.

    Research output: Contribution to journalArticle

    @article{93c2426fe6324dcbbebfc4478e398f61,
    title = "Estrogen and thrombosis: Controversies and common sense",
    abstract = "Soon after the introduction of hormonal oral contraceptive agents reports of thrombotic complications appeared. In the past several decades, large epidemiological studies helped defined these risks for both arterial and venous complications. Clinicians can assess a patient's risk of thrombosis by both composition of the agent and patients' personal risk factors. For women with bleeding disorders these prothrombotic changes can help decrease bleeding complications. There is now also abundant data on future management of patients with estrogen related thrombosis.",
    keywords = "Estrogen, Myocardial infraction, Stroke, Thrombophilia, Thrombosis",
    author = "Thomas Deloughery",
    year = "2011",
    month = "6",
    doi = "10.1007/s11154-011-9178-0",
    language = "English (US)",
    volume = "12",
    pages = "77--84",
    journal = "Reviews in Endocrine and Metabolic Disorders",
    issn = "1389-9155",
    publisher = "Springer Netherlands",
    number = "2",

    }

    TY - JOUR

    T1 - Estrogen and thrombosis

    T2 - Controversies and common sense

    AU - Deloughery, Thomas

    PY - 2011/6

    Y1 - 2011/6

    N2 - Soon after the introduction of hormonal oral contraceptive agents reports of thrombotic complications appeared. In the past several decades, large epidemiological studies helped defined these risks for both arterial and venous complications. Clinicians can assess a patient's risk of thrombosis by both composition of the agent and patients' personal risk factors. For women with bleeding disorders these prothrombotic changes can help decrease bleeding complications. There is now also abundant data on future management of patients with estrogen related thrombosis.

    AB - Soon after the introduction of hormonal oral contraceptive agents reports of thrombotic complications appeared. In the past several decades, large epidemiological studies helped defined these risks for both arterial and venous complications. Clinicians can assess a patient's risk of thrombosis by both composition of the agent and patients' personal risk factors. For women with bleeding disorders these prothrombotic changes can help decrease bleeding complications. There is now also abundant data on future management of patients with estrogen related thrombosis.

    KW - Estrogen

    KW - Myocardial infraction

    KW - Stroke

    KW - Thrombophilia

    KW - Thrombosis

    UR - http://www.scopus.com/inward/record.url?scp=79958149914&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=79958149914&partnerID=8YFLogxK

    U2 - 10.1007/s11154-011-9178-0

    DO - 10.1007/s11154-011-9178-0

    M3 - Article

    VL - 12

    SP - 77

    EP - 84

    JO - Reviews in Endocrine and Metabolic Disorders

    JF - Reviews in Endocrine and Metabolic Disorders

    SN - 1389-9155

    IS - 2

    ER -